Analysis of satisfaction with drug therapy for benign prostatic hyperplasia in elderly and senile patients

Popov S.V., Huseynov R.G., Sivak K.V., Pomeshkin E.V., Sengirbaev D.I., Perepelitsa V.V., Bunenkov N.S., Lelavina T.A.

1) GBUZ «City Hospital Saint Luka», Saint Petersburg, Russia; 2) FGBVOU VO S.M. Kirov Military Medical Academy of the Ministry of Defense of Russian Federation, Saint Petersburg, Russia; 3) FGBOU VO Saint-Petersburg State University, Saint Petersburg, Russia; 4) FGBOU VO Altai State Medical University of the Ministry of Health of Russia, Barnaul, Russia; 5) FGBU Smorodintsev Research Institute of Influenza of the Ministry of Health of Russia, Saint Petersburg, Russia; 6) FGBOU VO Pavlov First Saint Petersburg State Medical University of the Ministry of Health of Russia, Saint Petersburg, Russia; 7) PHEI «St. Petersburg Medical and Social Institute», Saint Petersburg, Russia; 8) NAO «Kazakh National Medical University named after S.D. Aspendiyarova», Almaty, Kazakhstan; 9) FGBU National Medical Research Center named after V.A. Almazov of the Ministry of Health of the Russian Federation, Saint Petersburg, Russia

Age is a non-modifiable risk factor for the development of benign prostatic hyperplasia (BPH). The algorithm of drug treatment of BPH is well known. From the perspective of modern patient-oriented medicine, when evaluating the efficiency of treatment, the subjective assessment by the patient, including satisfaction with the therapy, are important. Predictors of patients' dissatisfaction with drug therapy and low adherence to treatment are the persistence of lower urinary tract symptoms, especially nocturia, as well as the presence of erectile dysfunction. It is recommended to integrate the evaluation of treatment satisfaction into routine clinical practice, which will improve the quality of medical care. We have presented a literature review of satisfaction with drug therapy in elderly and senile patients with BPH, according to modern literature. The literature sources for 2018-2023 in the databases Springer, PubMed, eLibrary, Cyberleninca in Russian and English on the subjective assessments by patients of the older age of the treatment of BPH were analyzed.

Keywords

About the Authors

Corresponding author: T.A. Lelyavina – Ph.D., MD, leading researcher at the Research Institute of Microcirculation and Myocardial Metabolism, Institute of Experimental Medicine of FGBU National Medical Research Center named after V.A. Almazov of the Ministry of Health of the Russian Federation, Saint Petersburg, Russia; e-mail: tatianalelyavina@mail.ru

Similar Articles